Overview
- Description
Developer of next-generation biological drugs designed to treat wounds in skin and mucosa. The company's biological drug is a novel drug delivery system where lactic acid bacteria are used as vectors to produce and deliver biological drugs on-site to skin wounds or in the gastrointestinal tract, its human therapeutic proteins are delivered on-site in wounds by living lactic acid bacteria acting like small bioreactors, enabling patients with diabetes to get accelerated healing of a chronic wound in a cost-effective way.
- Website
- Country
- Sweden
- Sector
- Health Biotechnology